TPG Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

TPG Financial Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,131	Closed	-$2.05M	–	46
2022 Q2	$2.05M	Buy	15,131 +16	+0.1%	+$2.21K	1.37%	20
2022 Q1	$2.25M	Buy	15,115 +2,367	+19%	+$350K	1.36%	19
2021 Q4	$2.06M	Buy	12,748 +283	+2%	+$45.8K	1.26%	17
2021 Q3	$2.07M	Buy	12,465 +639	+5%	+$109K	1.37%	17
2021 Q2	$2.04M	Sell	11,826 -639	-5%	-$106K	1.43%	16
2021 Q1	$2M	Sell	12,465 -928	-7%	-$159K	1.4%	17
2020 Q4	$2.25M	Buy	13,393 +3,942	+42%	+$639K	1.67%	16
2020 Q3	$1.49M	Sell	9,451 -1,022	-10%	-$167K	1.27%	17
2020 Q2	$1.76M	Buy	+10,473	New	+$1.64M	1.58%	17

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

TPG Financial Advisors's FBT Position: Q3 2022 in Review

TPG Financial Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 15,131 shares — an estimated $2.05M sold.

TPG Financial Advisors first reported a position in FBT in Q2 2020 and held it in 9 quarters. The position peaked at $2.25M in Q1 2022. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

TPG Financial Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
TPG Financial Advisors sold 15,131 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $2.05M.
TPG Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 9 quarters.
TPG Financial Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.25M in Q1 2022.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on TPG Financial Advisors's 13F filing for Q3 2022, filed 11 Oct 2022.